Development and characterization of the monobactams: Aztreonam, a directed therapeutic agent
- 1 November 1984
- journal article
- Published by Elsevier in Antimicrobic Newsletter
- Vol. 1 (11) , 85-90
- https://doi.org/10.1016/0738-1751(84)90044-3
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Binding of monobactams to penicillin-binding proteins of Escherichia coli and Staphylococcus aureus: relation to antibacterial activityAntimicrobial Agents and Chemotherapy, 1983
- Interaction of azthreonam and related monobactams with beta-lactamases from gram-negative bacteriaAntimicrobial Agents and Chemotherapy, 1982
- Resistance to Cefamandole: Derepression of -Lactamases by Cefoxitin and Mutation in Enterobacter cloacaeThe Journal of Infectious Diseases, 1982
- Mode of action of azthreonamAntimicrobial Agents and Chemotherapy, 1982
- Single-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjectsAntimicrobial Agents and Chemotherapy, 1982
- The Classification and Terminology of Enzymes That Hydrolyze -Lactam AntibioticsThe Journal of Infectious Diseases, 1982
- Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteriaAntimicrobial Agents and Chemotherapy, 1982
- Monocyclic β-lactam antibiotics produced by bacteriaNature, 1981
- Monobactams--monocyclic -lactam antibiotics produced by bacteriaJournal of Antimicrobial Chemotherapy, 1981
- The β-lactamases of Gram-negative bacteria and their rôle in resistance to β-lactam antibioticsJournal of Antimicrobial Chemotherapy, 1976